No results for ‘’
Mercury Laboratories Ltd
₹850.70
(12.11%)
Sat, 20 Jun 2026, 10:16 pm
Health Technology
Pharmaceuticals: Major
24.5KMercury Laboratories Share Price Live Chart
1 Day
(12.11%)
No Result Found
Summary
Market Cap (in Cr)
91.61
Net Profit (in Cr)
3.14
P/B
1.83
Sector P/E
44.89
P/E
31.25
EV/EBITDA
12.55
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
6.01
ROCE
8.98
Debt/Equity
0.11
EPS (TTM)
41.22
Dividend Yield
0.46
Book Value
464.65
Interest Cover
9.47
Analysis
all
- Dividends paid are thoroughly covered by earnings (13.5x coverage).
- Mercury Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Mercury Laboratories is profitable, therefore cash runway is not a concern.
- Mercury Laboratories is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (86.8%, greater than 20% of total debt).
- Dividend payments have increased, but Mercury Laboratories only paid a dividend in the past 5 years.
- Whilst dividend payments have been stable, Mercury Laboratories has been paying a dividend for less than 10 years.
- Mercury Laboratories's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Mercury Laboratories's dividend is below the markets top 25% of dividend payers in India (3.08%).
- High level of physical assets or inventory.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 73.66 | 73.66 | 73.66 | 73.66 | 73.66 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 26.34 | 26.34 | 26.34 | 26.34 | 26.34 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1222.65 | 1013.15 | 888.30 | 803.65 | 678.80 | 594.15 | 384.65 |
| Fibonacci | 1013.15 | 933.12 | 883.68 | 803.65 | 723.62 | 674.18 | 594.15 |
| Camarilla | 821.06 | 801.86 | 782.65 | 803.65 | 744.25 | 725.04 | 705.84 |
Pivots Level: Classic
R3
+419.00
1222.65
R2
+209.50
1013.15
R1
+84.65
888.30
S1
-124.85
678.80
S2
-209.50
594.15
S3
-419
384.65
Moving Average
Period
Value
10-EMA
777.49
20-EMA
774.47
30-EMA
773.94
50-EMA
776.10
100-EMA
788.37
200-EMA
811.08
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 29 May 2026 | agm | ||
| 29 May 2026 | board-meetings | Accounts, Quarterly Results, Final Dividend | |
| 11 Feb 2026 | board-meetings | Quarterly Results | |
| 06 Jul 2025 | dividend | Final Dividend - Rs. - 3.5 | 06 Aug 2025 |
| 14 May 2025 | dividend | ₹3.50 Dividend /Share | 06 Aug 2025 |
| 14 May 2025 | agm | ||
| 24 Jul 2024 | agm | ||
| 28 May 2024 | dividend | ₹3.50 Dividend /Share | 21 Sept 2024 |
| 05 May 2023 | agm | ||
| 05 May 2023 | dividend | ₹3.50 Dividend /Share | 21 Sept 2023 |
Peer Comparison
Mercury Laboratories Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Mercury Laboratories Ltd About
Mercury Laboratories is engaged into the manufacturing and export of wide range of Pharmaceutical items.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1982
Headquarters
CEO
SANJAY SHANTILAL PATEL
Employees
Contact
Website
http://www.mercurylabs.com
secretarial@mercurylabs.com, mllbrd@mercurylabs.co
Phone
91-22-66372841
Location
1st Floor 18 Shreeji Bhuwan 51, Princess Street Mangaladas Rd, Mumbai, Maharashtra, 400002
Mercury Laboratories Ltd Company History
| Year | History |
|---|---|
| 1982 |
|
| 1992 |
|
| 2015 |
|